Navigation Links
Nano Mask Names Dr. Hassan Bennani to Board of Directors
Date:1/24/2013

FISHKILL, N.Y., Jan. 24, 2013 /PRNewswire/ -- Nano Mask, Inc., (PINKSHEETS: NANM), a materials technology development company focused on health and wellness related markets, today announced that it has appointed Hassan Bennani , MD, to its Board of Directors.

Dr. Bennani is the co-founder and CEO of KellBenx, Incorporated, a closely held Long Island, NY based biotechnology company focused on women's healthcare, concentrating on the development of a patented breakthrough non-invasive prenatal diagnostic (NIPD) for analyzing genetic disorders and a patent pending breakthrough test to determine a woman's risk of preterm delivery.

Dr. Bennani was previously the head of business development at Lenetix, a women's health focused lab acquired by Bio-Reference Laboratories.  Prior to that, Dr. Bennani was a Vice President of Sales and Marketing for Adeza Biomedical Corporation, which was acquired by Hologic.  

"I am excited about joining forces with Nano Mask , which has assembled an impressive hospital textile product portfolio that can grow its sales significantly over the next few years," said Dr. Bennani, who went on to add, "I am confident that the industry contacts that I have made over the course of my career, especially in international markets, will be very receptive to Nano Mask 's products."

"Dr. Bennani's extensive experience and network make him ideally suited to help promote our products both in the United States and internationally," said Edward Suydam , President and CEO, Nano Mask Inc.

About Nano Mask , Inc.

We are a healthcare product development and distribution company providing innovative and cost effective emergency and critical care and infection control products
'/>"/>

SOURCE Nano Mask , Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SPIE Names 69 New Fellows of the Society in 2013
2. PathoGenetix Names Ann Merrifield as Chief Executive Officer and Prepares to Launch Unique Bacterial Identification Technology
3. AtheroNova Names New Director
4. FierceBiotech Names Enanta Pharmaceuticals, Inc. a Fierce 15 Winner
5. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
6. Islet Sciences Names Richard A. Franco, Sr. to its Board of Directors
7. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
8. PharmaVOICE Names Four inVentiv Health Associates Among "100 Most Inspiring" Leaders in Healthcare
9. Lloyd Library and Museum Names ABCs Blumenthal to New Honorary Advisory Board
10. Ethical Corporation Names Life Technologies First CSO Sustainability Executive of the Year
11. Triple-S Management Corporation Announces the Retirement of Socorro Rivas-Rodriguez; Names Pablo Almodovar Scalley as Successor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... On October 26th at the Mid ... leading applied stem cell research scientist Neil Riordan, ... talks on New Techniques for Enhancing Stem Cell ... Cells. , Dr. Riordan focused on historical medical ... AlphaGEMS that include: wound healing; inflammation and pain ...
(Date:10/30/2014)... Boston, MA (PRWEB) October 30, 2014 James ... new advance in adult tissue stem cell technology since his ... Center (FCCC) in Philadelphia in the late 1990’s. Sherley ... year. The company holds all the intellectual property developed ... a professor at the Massachusetts Institute of Technology (MIT), and ...
(Date:10/30/2014)... 2014 Avure Technologies celebrates a year of ... member of its fleet of high volume High Pressure Processing ... as we return to PackExpo this year, which is where ... Vegas,” said Jeff Williams, CEO at Avure. “Sales of the ... to be meeting the challenges of market demand for higher ...
(Date:10/30/2014)... Oct. 30, 2014 A new report, commissioned ... Practice, takes an in-depth look at Indiana,s ... have resulted over two different time frames: 1993 to ... view of future opportunities for investment growth.  The ... report shows gains in innovation dollars as well ...
Breaking Biology Technology:Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 2Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 3Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 4Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3New report shows Indiana's gains in life sciences innovation capital outpace the nation 2New report shows Indiana's gains in life sciences innovation capital outpace the nation 3New report shows Indiana's gains in life sciences innovation capital outpace the nation 4New report shows Indiana's gains in life sciences innovation capital outpace the nation 5
... Dan Ross to Lead Business Development Team , , ... that provides pricing and reimbursement services to pharmaceutical and biotechnology companies, ... open its new San Diego office. , , ... both investment banking and strategic consulting capacities. His primary role ...
... INCLINE VILLAGE, Nev., Sept. 8 PDL BioPharma, Inc. ... for the third quarter ended September 30, 2009 of approximately ... quarter of 2008. Royalty revenues are based on second quarter ... Synagis(R), which is marketed by MedImmune. When compared with 2008, ...
... Sept. 8 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.,(NYSE Amex: ... announced,that the first lot of PANFLU.1, its H1N1 vaccine, has ... Control of Pharmaceutical and,Biological Products and obtained the Certificate for ... ready for delivery. , The released ...
Cached Biology Technology:PriceSpective Continues Global Expansion With New San Diego Office 2PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately $71 Million 2PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately $71 Million 3Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine 2
(Date:10/29/2014)... a consequence of chemotherapy will benefit from a major ... that prevents hair loss. , The research is being ... cooling manufacturing company, Paxman Coolers, of Fenay Bridge, Huddersfield, ... of Huddersfield. , The research will be led by ... the pharmacology of cancer treatment, which he will use ...
(Date:10/29/2014)... Beaverton, OR) New research presented at the ... in Houston, TX showed for the first time ... in women using a readily available nutritional supplement, ... by Dr. Judith A. Smith, Pharm.D., associate professor ... Sciences at The University of Texas Health Science ...
(Date:10/29/2014)... factors, both genetic and environmental, have been blamed ... schizophrenia. Some, such as a family history of ... with Toxoplasma gondii , a parasite transmitted ... still viewed with skepticism. , A new study ... epidemiology at the University of Pennsylvania,s School of ...
Breaking Biology News(10 mins):New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Penn vet professor investigates parasite-schizophrenia connection 2Penn vet professor investigates parasite-schizophrenia connection 3
... the brain than previously thought, a new study shows. ... first detected by part of the brain called primary visual ... head where visual information first enters the cortex of the ... in animals but has not been tested on human beings ...
... (September 5, 2007) King Abdullah University of Science ... Cairo (AUC) signed a Memorandum of Understanding on August ... development that will positively impact the Kingdom of Saudi ... president of KAUST, and Dr. David D. Arnold, president of ...
... of Engineering may have discovered the path toward ... bacteria that have developed resistance to common antibiotics. ... of events occurring in bacteria that opens to ... Currently, three classes of bactericidal antibiotics are used ...
Cached Biology News:Color contrast is 'seen' by the brain early doors 2KAUST and American University in Cairo to collaborate on research and academic development 2Boston University biomedical engineers find chink in bacteria's armor 2Boston University biomedical engineers find chink in bacteria's armor 3
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Arginine vasopressin receptor (AVP-V2), rat. The peptide used for immunization has no significant similarity with AVP V1a or V1b receptors....
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications)....
Rabbit polyclonal to Orexin Prepro ( Abpromise for all tested applications). entrezGeneID: 3060 SwissProtID: O43612...
Biology Products: